Unichem Laboratories (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Unichem Laboratories Limited |
|||
|
Price: ₹719.25 | ||
| 52 Week Low: ₹400.55 52 Week High: ₹937.95 |
|||
| Market Capital: 3,895.2 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Unichem Laboratories Share Price Target For 2024
- 1.1.1: Unichem Laboratories Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Unichem Laboratories Share Price Target For 2025
- 1.2.1: Unichem Laboratories Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Unichem Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Unichem Laboratories Brief Company Overview
- 4: Unichem Laboratories Financial Performance
- 4.0.1: Is Unichem Laboratories A Good Buy For Long Term?
To predict the Unichem Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Unichem Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Unichem Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Unichem Laboratories shares in 2024, see the table below.
Unichem Laboratories Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 775.0 (+7.75%) | Price Action: 10 Dec 2024 Low |
| 2024 Target 2 | 763.84 (+6.19%) | Price Action: 28 Oct 2024 Low |
| 2024 Target 1 | 754.0 (+4.83%) | Price Action: 09 Dec 2024 Low |
| Current Price | 719.25 | Unichem Laboratories's share price as of 20 Dec 2024 |
| Stop Loss 1 | 703.96 (-2.13%) | Technical Indicator: MA100 |
| Stop Loss 2 | 694.7 (-3.42%) | Price Action: Sep 2024 High |
| Stop Loss 3 | 682.2 (-5.16%) | Price Action: Chart |
Short-Term Technical Outlook
Current Technical Position: Unichem Laboratories is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹810.66 serves as the nearest technical reference point.
Historical Returns: 3-month: +9.29% | 6-month: +35.21% | 1-year: +77.20%
Unichem Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Unichem Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Unichem Laboratories shares in 2025, see the table below.
Unichem Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1095.86 (+52.36%) | Price Action: Chart |
| 2025 Target 2 | 1075.43 (+49.52%) | Price Action: Chart |
| 2025 Target 1 | 1064.78 (+48.04%) | Fibonacci Extension Level 123.60% |
| Current Price | 719.25 | Unichem Laboratories's share price as of 20 Dec 2024 |
| Stop Loss 1 | 631.0 (-12.27%) | Price Action: Aug 2024 High |
| Stop Loss 2 | 621.66 (-13.57%) | Technical Indicator: MA200 |
| Stop Loss 3 | 610.47 (-15.13%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Unichem Laboratories is currently trading at 59.3% of its 52-week range (₹400.55 - ₹937.95).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +77.20% | 3-year: +193.10% | 5-year: +376.70%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Unichem Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹719.25 | ||
| 2024 | ₹963.25 | +33.92% | ₹977.70 |
| 2025 | ₹1,444.70 | +49.98% | ₹1,466.37 |
| 2026 | ₹1,853.21 | +28.28% | ₹1,881.01 |
| 2027 | ₹2,543.01 | +37.22% | ₹2,581.16 |
| 2028 | ₹3,266.33 | +28.44% | ₹3,315.32 |
| 2029 | ₹3,747.12 | +14.72% | ₹3,803.33 |
| 2030 | ₹4,090.62 | +9.17% | ₹4,151.98 |
| 2031 | ₹4,337.36 | +6.03% | ₹4,691.42 |
| 2032 | ₹5,231.15 | +20.61% | ₹5,403.97 |
| 2033 | ₹6,116.51 | +16.92% | ₹6,208.26 |
| 2034 | ₹6,531.00 | +6.78% | ₹6,628.96 |
| 2035 | ₹6,736.53 | +3.15% | ₹6,837.58 |
| 2036 | ₹6,821.51 | +1.26% | ₹7,541.60 |
| 2037 | ₹7,919.29 | +16.09% | ₹8,254.14 |
| 2038 | ₹8,966.68 | +13.23% | ₹9,101.18 |
| 2039 | ₹8,655.85 | -3.47% | ₹8,785.69 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Unichem Laboratories Brief Company Overview
Unichem Laboratories Limited: A Pioneer in Pharmaceuticals Established in 1944, Unichem Laboratories Limited is a renowned pharmaceutical company headquartered in Mumbai, India. With a global presence, the company has established itself as a trusted provider of quality...
pharmaceutical products. Key Products and Services: Formulation products for various therapeutic areas (gastroenterology, cardiology, diabetology, etc.) Active pharmaceutical ingredients Contract manufacturing services Allopathic medicines Bulk drugs Chemicals Unichem Laboratories Limited is renowned for its diverse product range, commitment to innovation, and adherence to the highest industry standards.Unichem Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3,895.2 Crore | Market valuation of Unichem Laboratories's shares. |
| Revenue (TTM) | 1,675.29 Crore | Total revenue generated by Unichem Laboratories over the past twelve months. |
| Net Income (TTM) | +145,688,000.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.36% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +0.86% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+43.60% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+19.42% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
12.05 | Company's total debt divided by total shareholder equity. |
| Total Debt | 290.16 Crore | Sum of Unichem Laboratories's current & long-term financial obligations. |
| Total Cash | 66.13 Crore | Total amount of liquid funds available to Unichem Laboratories. |
| Beta | 0.14 | Beta is less than 1 indicating that the Unichem Laboratories's price is less volatile than the market. |
Is Unichem Laboratories A Good Buy For Long Term?
Based on the provided data, Unichem Laboratories appears to be a promising long-term investment option. Its recent financial performance shows steady growth, with a 19.42% increase in earnings and a 43.6% increase in revenue compared to the same period last year. The company's profitability, as indicated by its net profit margin of 0.86%, is also within a reasonable range. Furthermore, its strong historical returns, including over 100% growth in the past three and five years, demonstrate its potential for long-term capital appreciation. While the company's debt of 290.16 Crore warrants attention, it is partially offset by its healthy cash balance of 66.13 Crore. Overall, Unichem Laboratories presents a compelling investment opportunity for those seeking long-term growth potential.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
